









Markets
/
Stocks
/
nasdaq-tivc
/

Tivic Health Systems Inc

TIVC

0.850USD

-0.139-14.04%

Close 03/30, 16:00（ET）Quotes delayed by 15 min

821.01KMarket Cap

LossP/E TTM



Tivic Health Systems Inc

0.850

-0.139-14.04%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Tivic Health Systems Inc

Currency: USD Updated: 2026-03-27

Key Insights

Tivic Health Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 156 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Tivic Health Systems Inc's Score

Industry at a Glance

Industry Ranking

156 / 208

Overall Ranking

496 / 4542

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Tivic Health Systems Inc Highlights

StrengthsRisks

Tivic Health Systems, Inc. is a diversified therapeutics company, with complementary bioelectronic and biologic product candidates in its clinical pipeline. It harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. It takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. It also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.

Growing

The company is in a growing phase, with the latest annual income totaling USD 780.00K.

Overvalued

The company’s latest PE is -0.00, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 224.75K shares, increasing 39.19% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 1.94K shares of this stock.

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of Tivic Health Systems Inc is 7.09, ranking 89 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 146.00K, representing a year-over-year increase of 15.87%, while its net profit experienced a year-over-year increase of 81.41%.

Score

Industry at a Glance

Previous score

7.09

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.37

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.92

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.95

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.21

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Tivic Health Systems Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of Tivic Health Systems Inc is 6.75, ranking 151 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.00, which is -4410.34% below the recent high of 0.12 and -51910.34% above the recent low of -1.51.

Score

Industry at a Glance

Previous score

6.75

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 156/208

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

No earnings forecast score is currently available for Tivic Health Systems Inc. The Healthcare Equipment & Supplies industry's average is 7.78.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of Tivic Health Systems Inc is 1.73, ranking 203 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 1.21 and the support level at 0.69, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.76

Change

-0.03

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.012

Neutral

RSI(14)

43.114

Neutral

STOCH(KDJ)(9,3,3)

22.874

Sell

ATR(14)

0.130

Low Volatility

CCI(14)

-108.111

Sell

Williams %R

87.513

Oversold

TRIX(12,20)

0.501

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.986

Sell

MA10

0.965

Sell

MA20

0.924

Sell

MA50

0.960

Sell

MA100

1.391

Sell

MA200

2.372

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of Tivic Health Systems Inc is 3.00, ranking 135 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 8.90%, representing a quarter-over-quarter increase of 211.56%. The largest institutional shareholder is The Vanguard, holding a total of 1.94K shares, representing 0.08% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Avenue Capital Group

101.64K

Marex Group plc

38.39K

-2.27%

Ernst (Jennifer)

32.69K

+40.62%

UBS Financial Services, Inc.

801.00

-85.83%

Geode Capital Management, L.L.C.

5.07K

Citi Investment Research (US)

1.43K

The Vanguard Group, Inc.

Star Investors

1.94K

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Tivic Health Systems Inc is 1.56, ranking 183 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.82. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.